Equity Overview
Price & Market Data
Price: $11.65
Daily Change: -$0.09 / 0.77%
Daily Range: $11.42 - $12.00
Market Cap: $354,704,832
Daily Volume: 153,705
Performance Metrics
1 Week: 26.22%
1 Month: -15.09%
3 Months: -10.38%
6 Months: -15.58%
1 Year: -61.36%
YTD: -1.77%
Company Details
Employees: 26
Sector: Health technology
Industry: Biotechnology
Country:
Details
Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates. Its pipeline includes CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics, including novel combinations. The company is headquartered in Waltham, Massachusetts.